Zydus Lifesciences Limited — Financials & Forensics
Sector: Healthcare · NSE: ZYDUSLIFE · BSE: 532321 · ISIN: INE010B01027
19 Aug 2026
Add ZYDUSLIFE to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue from operations | ₹15,265 Cr | ₹17,237 Cr | ₹19,547 Cr | ₹23,242 Cr | ₹27,148 Cr |
| EBITDA | ₹3,341 Cr | ₹3,860 Cr | ₹5,384 Cr | ₹7,058 Cr | ₹8,475 Cr |
| EBITDA margin | 21.9% | 22.4% | 27.5% | 30.4% | 31.2% |
| Profit after tax | ₹2,326 Cr | ₹2,002 Cr | ₹3,831 Cr | ₹147 Cr | ₹5,040 Cr |
Deeper analysis
Recent filings by Zydus Lifesciences Limited
-
Analysts/Institutional Investor Meet/Con. Call Updates
18 Aug 2026 · Financial Results
-
Analysts/Institutional Investor Meet/Con. Call Updates
17 Aug 2026 · General Update
-
Analysts/Institutional Investor Meet/Con. Call Updates
12 Aug 2026 · General Update
-
Copy of Newspaper Publication
12 Aug 2026 · Regulatory Compliance
-
Regulation 44(3) disclosure of AGM 2026
11 Aug 2026 · Corporate Action
Never miss a filing again
About Zydus Lifesciences Limited on Indian Stock Alerts
Indian Stock Alerts tracks Zydus Lifesciences Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.